SANOFINSESanofi India Limited· PharmaceuticalsMinimalNeutral
Announced Mon, 13 Oct · 17:42 IST

Sanofi India Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2025 provided by RTA.

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sanofi India Limited has submitted a certificate from its Registrar and Transfer Agent (RTA) as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate covers the quarter ended 30th September 2025. Such certificates are filed periodically to confirm compliance with depository-related procedures, including the reconciliation of dematerialized (demat) shares and proper handling of share transfers. The filing is a routine regulatory obligation and does not involve any change in business operations, financials, or shareholding structure.

Likely market impact

This is a standard procedural compliance filing with no material impact on shareholders, company financials, or the stock price. Investors should view it as routine housekeeping required by market regulators.